WuXi PharmaTech (WX) Tops Q2 EPS by 1c

WuXi PharmaTech (NYSE: WX) reported Q2 EPS of $0.33, $0.01 better than the analyst estimate of $0.32. Revenue for the quarter came in at $130.4 million versus the consensus estimate of $126.65 million.

For earnings history and earnings-related data on WuXi PharmaTech (WX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• S&P downgrades Cable One to ’B+’ on weakening broadband outlook
• Freedom Broker Starts Autoliv, Inc. (ALV) at Buy